Stereoselective Pharmacokinetics of Chlorpheniramine and the Effect of Ranitidine

Cross, 1991, A consideration of the enzymology underlying ranitidine metabolism and drug interactions, J. Biopharm. Sci, 2, 339 Roth, 1958, Comparative pharmacology of chlorpheniramine (Chlor-Trimeton) and its optical isomers, J. Pharmacol. Exp. Ther., 124, 347 Nicholson, 1991, Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene, Br. J. Pharmacol., 104, 270, 10.1111/j.1476-5381.1991.tb12418.x Miyazaki, 1976, Mass fragmentographic determination of d- and l-chlorpheniramine with the aid of the stable isotope technique, Chem. Pharm. Bull., 24, 2572, 10.1248/cpb.24.2572 Fujiwara, 1989, Behavior of chlorpheniramine in vivo after administration of d- and l-chlorpheniramine maleate, Yakugaku Zasshi, 109, 59, 10.1248/yakushi1947.109.1_59 Huang, 1982, Pharmacokinetics of chlorpheniramine after oral and intravenous administration in normal subjects, Eur. J. Clin. Pharmacol., 359, 10.1007/BF00548406 Peets, 1972, Metabolism of Chlorpheniramine Maleate in Man, J. Pharmacol. Exp. Ther., 180, 464 Lai, 1979, Urinary Excretion of Chlorpheniramine and Pseudoephedrine in Humans, J. Pharm. Sci., 68, 1243, 10.1002/jps.2600681012 Beckett, 1965, Influence of urine pH and flow rate on the renal excretion of chlorpheniramine in man, J. Pharm. Pharmacol., 17, 256, 10.1111/j.2042-7158.1965.tb07663.x Simons, 1984, Urinary excretion of chlorpheniramine and its metabolites in children, J. Pharm. Sci., 73, 595, 10.1002/jps.2600730505 Yacobi, 1980, Evaluation of sustained-action chlorpheniramine-pseudoephedrine dosage form in humans, J. Pharm. Sci., 69, 1077, 10.1002/jps.2600690924 Jersey, 1994, Determination of Chlorpheniramine in Serum Employing Solid-Phase Extraction and GC/MS/SIM, 94 Jersey, 1994, Trace Level Chiral Quantification of Chlorpheniramine from Serum Employing Solid-Phase Extraction and GC/MS/SIM, 94 Minser, 1995 Koch, 1972, The use of nonparametric methods in the statistical analysis of the two period changeover design, Biometrics, 28, 577, 10.2307/2556170 Kotzan, 1982, Bioavailability of Regular and Controlled-Release Chlorpheniramine Products, J. Pharm. Sci., 71, 919, 10.1002/jps.2600710820 Cashman, 1992, Enantioselective N-oxygenation of chlorpheniramine by the flavin-containing monooxygenase from hog liver, Xenobiotica, 22, 459, 10.3109/00498259209046658 Nomura, 1997, Stereoselective N- Demethylation of Chlorpheniramine by Rat-liver Microsomes and the Involvement of Cytochrome P450 Isozymes, J. Pharm. Pharmacol, 49, 257, 10.1111/j.2042-7158.1997.tb06791.x Sakurai, 1992, The Optical Resolution of Racemic Chlorpheniramine and Its Stereoselective Pharmacokinetics in Rat Plasma, J. Pharm. Pharmacol, 44, 44, 10.1111/j.2042-7158.1992.tb14361.x